Recent studies revealed that the calcium/calmodulin-dependent protein kinase 1D (CAMK1D) and the m6A demethylase Alkbh5 may regulate the tumor cells refractory to anti-PD-L1 treatment (106, 107). The gene discussed is CD274; the disease is neoplasm.